fingolimod hydrochloride has been researched along with oxazoles in 5 studies
| Studies (fingolimod hydrochloride) | Trials (fingolimod hydrochloride) | Recent Studies (post-2010) (fingolimod hydrochloride) | Studies (oxazoles) | Trials (oxazoles) | Recent Studies (post-2010) (oxazoles) |
|---|---|---|---|---|---|
| 2,771 | 157 | 2,062 | 9,281 | 366 | 2,561 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blankenbach, K; Engelhardt, B; Enzmann, G; Fallegger, D; Homann, T; Huwiler, A; Imeri, F; Kleuser, B; Meyer zu Heringdorf, D; Pfeilschifter, J; Schwalm, S; Stark, H; Zivkovic, A | 1 |
| Azumaya, I; Hamada, M; Hikawa, H; Kikkawa, S; Uchida, Y; Yokoyama, Y | 1 |
| Engelhardt, B; Huwiler, A; Imeri, F; Lyck, R; Pfeilschifter, J; Schwalm, S; Stark, H; Zivkovic, A | 1 |
| Chen, X; Ji, M; Jin, J; Lai, F; Wang, Y; Xue, N; Zhang, S; Zhang, X | 1 |
| Hu, J; Li, Y; Yang, S; Zhao, Z | 1 |
5 other study(ies) available for fingolimod hydrochloride and oxazoles
| Article | Year |
|---|---|
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Topics: Animals; Cell Line; Cell Membrane Permeability; Cells, Cultured; Chemotaxis; CHO Cells; Cricetulus; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Female; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Lymphocytes; Mice; Mice, Inbred C57BL; Oxazoles; Propylene Glycols; Receptors, Lysosphingolipid; Sphingosine; T-Lymphocytes; U937 Cells | 2014 |
Enantioselective desymmetrization of FTY720.
Topics: Acylation; Benzoates; Catalysis; Coordination Complexes; Copper; Fingolimod Hydrochloride; Oxazoles; Propylene Glycols; Solvents; Sphingosine; Stereoisomerism | 2014 |
Sphingosine kinase 2 deficient mice exhibit reduced experimental autoimmune encephalomyelitis: Resistance to FTY720 but not ST-968 treatments.
Topics: Animals; Blood-Brain Barrier; Encephalomyelitis, Autoimmune, Experimental; Endothelial Cells; Fingolimod Hydrochloride; Gene Knockdown Techniques; Immunologic Factors; Intercellular Adhesion Molecule-1; Mice; Mice, Inbred C57BL; Oxazoles; Phosphotransferases (Alcohol Group Acceptor); Primary Cell Culture; RNA, Messenger; T-Lymphocytes | 2016 |
Validating a Selective S1P
Topics: Administration, Oral; Animals; Animals, Outbred Strains; Anti-Inflammatory Agents, Non-Steroidal; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fingolimod Hydrochloride; Guinea Pigs; Mice; Mitotic Index; Mucous Membrane; Oxazoles; Propanolamines; Psoriasis; Random Allocation; Receptors, Lysosphingolipid; Reproducibility of Results; Skin; Specific Pathogen-Free Organisms; Sphingosine-1-Phosphate Receptors; Vagina | 2018 |
CYP2J2 is the major enzyme in human liver microsomes responsible for hydroxylation of SYL-927, a novel and selective sphingosine 1-phosphate receptor 1 (S1P
Topics: Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme System; Fingolimod Hydrochloride; Humans; Hydroxylation; Microsomes, Liver; Oxazoles; Sphingosine-1-Phosphate Receptors | 2018 |